| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |